Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer

Harriet O. Smith, James Moon, Sharon P. Wilczynski, Amy D. Tiersten, Edward V. Hannigan, William R. Robinson, Saul E. Rivkin, Garnet L. Anderson, P. Y. Liu, Maurie Markman

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences